We are live on ! Find out more
CLLS

Cellectis
CLLS

44 hedge funds and large institutions have $176M invested in Cellectis in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

8% less funds holding

Funds holding: 48 → 44 (-4)

19% less capital invested

Capital invested by funds: $219M → $176M (-$42.4M)

29% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 14

36% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 11

Holders
44
Holders Change
-4
Holders Change %
-8.33%
% of All Funds
1.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
10
Reduced
14
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
THSP
Taube Hodson Stonex Partners
United Kingdom
+$4.1M
2
TCM
Tekla Capital Management
Massachusetts
+$2.48M
3
VIA
Vident Investment Advisory
Georgia
+$561K
4
LCM
Landscape Capital Management
New Jersey
+$397K
5
HighTower Advisors
HighTower Advisors
Illinois
+$323K

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$9.31M
2
Millennium Management
Millennium Management
New York
-$3.85M
3
BA
BlackRock Advisors
Delaware
-$2.9M
4
Goldman Sachs
Goldman Sachs
New York
-$1.8M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$1.77M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$96.5M – – –
CAM
2
Cormorant Asset Management
Massachusetts
$12.9M – – –
O
3
OrbiMed
New York
$9.63M – – –
TCM
4
Tekla Capital Management
Massachusetts
$8.53M +$2.48M +103,000 +50%
Lazard Asset Management
5
Lazard Asset Management
New York
$7.12M -$78.9K -3,275 -1%
Franklin Resources
6
Franklin Resources
California
$6.7M – – –
AG
7
Artal Group
Luxembourg
$5.78M – – –
THSP
8
Taube Hodson Stonex Partners
United Kingdom
$4.68M +$4.1M +170,112 New
CCP
9
Clough Capital Partners
Massachusetts
$4.43M -$1.14M -47,150 -23%
A
10
Abingworth
United Kingdom
$2.73M – – –
UBS Group
11
UBS Group
Switzerland
$2.54M -$151K -6,250 -6%
LCM
12
Landscape Capital Management
New Jersey
$1.97M +$397K +16,500 +30%
Hudson Bay Capital Management
13
Hudson Bay Capital Management
Connecticut
$1.53M -$185K -7,700 -12%
Citadel Advisors
14
Citadel Advisors
Florida
$1.42M -$290K -12,055 -19%
BBA
15
Baker Bros. Advisors
New York
$1.38M – – –
PI
16
Putnam Investments
Massachusetts
$1.1M – – –
TAM
17
Tocqueville Asset Management
New York
$787K +$108K +4,500 +19%
Millennium Management
18
Millennium Management
New York
$760K -$3.85M -159,761 -85%
PMAM
19
Picton Mahoney Asset Management
Ontario, Canada
$737K +$187K +7,750 +41%
ACA
20
Avoro Capital Advisors
New York
$688K -$241K -10,000 -29%
NIP
21
Nicholas Investment Partners
California
$513K -$123K -5,090 -21%
ARTA
22
A.R.T. Advisors
New York
$494K -$708K -29,400 -62%
Bank of America
23
Bank of America
North Carolina
$404K +$87K +3,613 +33%
HighTower Advisors
24
HighTower Advisors
Illinois
$369K +$323K +13,400 New
Deutsche Bank
25
Deutsche Bank
Germany
$361K -$698K -28,968 -69%
1
2 3

CLLS Hedge Fund Activity: Q1 2016 in Review

44 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q1 2016, worth a combined $176M — down 19% from $219M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of CLLS and 7 opened new positions — a net loss of 4 holders — while 14 trimmed existing stakes and 10 added.

The largest buyer was Taube Hodson Stonex Partners, opening a new position worth an estimated $4.1M. The largest seller was JP Morgan Chase, exiting entirely with an estimated $9.31M sold.

  • 44 institutional investors held Cellectis (CLLS) as of Q1 2016, down from 48 in Q4 2015.
  • Funds reported $176M of Cellectis stock for Q1 2016, down 19% quarter-over-quarter.
  • 7 funds opened new Cellectis positions in Q1 2016 and 11 closed out, a net change of -4 holders.
  • The largest Cellectis buyer in Q1 2016 was Taube Hodson Stonex Partners, an estimated $4.1M added.
  • The largest Cellectis seller in Q1 2016 was JP Morgan Chase, an estimated $9.31M sold.

Based on aggregated 13F filings for Q1 2016.